Literature DB >> 20463671

Animal models of epidermolysis bullosa: update 2010.

Leena Bruckner-Tuderman1, John A McGrath, E Clare Robinson, Jouni Uitto.   

Abstract

Mesh：

Year:  2010        PMID： 20463671     DOI： 10.1038/jid.2010.75

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  19 in total

1.  A direct method to determine the strength of the dermal-epidermal junction in a mouse model for epidermolysis bullosa.

Authors:  Thomas J Sproule; Derry C Roopenian; John P Sundberg
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

Review 2.  Laminin 332 in junctional epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Cristina Has; Leena Bruckner-Tuderman
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 3.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

Review 4.  Novel molecular therapies for heritable skin disorders.

Authors:  Jouni Uitto; Angela M Christiano; W H Irwin McLean; John A McGrath
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

Review 5.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

6.  Spontaneous KRT5 Gene Mutation in Rhesus Macaques (Macaca mulatta): A Novel Nonhuman Primate Model of Epidermolysis Bullosa Simplex.

Authors:  Amanda L Johnson; Samuel M Peterson; Margaret M L Terry; Betsy Ferguson; Lois M Colgin; Anne D Lewis
Journal:  Vet Pathol       Date:  2020-02-25       Impact factor: 2.221

Review 7.  Molecular therapeutics for heritable skin diseases.

Authors:  Jouni Uitto
Journal:  J Invest Dermatol       Date:  2012-11-15       Impact factor: 8.551

Review 8.  RNA-based therapies for genodermatoses.

Authors:  Olivier Bornert; Patricia Peking; Jeroen Bremer; Ulrich Koller; Peter C van den Akker; Annemieke Aartsma-Rus; Anna M G Pasmooij; Eva M Murauer; Alexander Nyström
Journal:  Exp Dermatol       Date:  2017-01       Impact factor: 3.960

9.  Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease.

Authors:  Blake R C Smith; Alexander Nyström; Cameron J Nowell; Ingrid Hausser; Christine Gretzmeier; Susan J Robertson; George A Varigos; Cristina Has; Johannes S Kern; Ken C Pang
Journal:  Dis Model Mech       Date:  2021-06-04       Impact factor: 5.758

10.  Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect.

Authors:  Alexander Nyström; Jens Buttgereit; Michael Bader; Tatiana Shmidt; Cemil Ozcelik; Ingrid Hausser; Leena Bruckner-Tuderman; Johannes S Kern
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.